Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:Japan
gptkb:South_Korea |
| gptkbp:ATCCode |
N05AX13
|
| gptkbp:CASNumber |
gptkb:132539-06-1
|
| gptkbp:developedBy |
gptkb:Japan
|
| gptkbp:drugClass |
antipsychotic medication
|
| gptkbp:hasMolecularFormula |
C21H27FN2O3S
|
| gptkbp:hasUNII |
6T6UO8361S
|
| https://www.w3.org/2000/01/rdf-schema#label |
D07481
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Dainippon_Sumitomo_Pharma
|
| gptkbp:mechanismOfAction |
dopamine D2 receptor antagonist
serotonin 5-HT2A receptor antagonist |
| gptkbp:molecularWeight |
406.52 g/mol
|
| gptkbp:PubChem_CID |
60727
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:blonanserin
|
| gptkbp:usedFor |
schizophrenia
|
| gptkbp:bfsParent |
gptkb:atorvastatin
|
| gptkbp:bfsLayer |
6
|